IP Library Granted Patent US 12,287,327
Granted Patent B2
US 12,287,327 · App. 17/752,597 · Granted Apr 29, 2025

Method of determining a concentration of an analyte in a bodily fluid

Inventors: Benhur Aysin (Indianapolis, IN); Max Berg (Mannheim, DE); Siva Chittajallu (Indianapolis, IN)
Assignee: Roche Diabetes Care, Inc.
G01N33/521G06T7/0014G06T7/90G06T2207/10024G06T2207/20084G06T2207/30004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,287,327
App. No.
17/752,597
Granted
Apr 29, 2025
Kind
B2
Abstract

A method is disclosed for determining concentration of an analyte in a body fluid with a mobile device having a camera. The camera captures an image of an optical test strip having a test field. The analyte concentration value is determined from color formation of the test field. Provided in the mobile device is a correlation for transforming color formation of the test field into analyte concentration. Also provided in the mobile device is an item of clearance information indicating a level of confidence for the correlation. When the item of clearance information indicates a sufficient level of confidence for the correlation, the mobile device indicates to a user that the capturing of the image does not require using a color reference card. Further disclosed are a method of controlling analytical measurements, a mobile device, a system for controlling analytical measurements and computer programs for performing and/or controlling analytical measurements.

Claims (31)

1. A method of determining a concentration of an analyte in a body fluid with a mobile device having a camera, the method comprising:

evaluating a plurality of analytical measurements and thereby determining a correlation wherein the correlation is configured for transforming color formation of a test field into an analyte concentration without requiring the use of a color reference card;

using the camera to capture an image of at least a part of an optical test strip having a test field;

determining an analyte concentration value from color formation of the test field of the optical test strip;

providing, in the mobile device, the correlation for transforming color formation of the test field into the analyte concentration;

providing, in the mobile device, an item of clearance information indicating a level of confidence for the correlation; and

when the item of clearance information indicates a sufficient level of confidence for the correlation, the mobile device providing an indication to a user that the capturing of the image does not require using a color reference card.

2. The method according to claim 1 , wherein the item of clearance information comprises a clearance information flag having a state indicating an insufficient level of confidence and a state indicating a sufficient level of confidence.

3. The method according to claim 1 , further comprising: when the item of clearance information indicates an insufficient level of confidence for the correlation, the mobile device indicating to a user that the capturing of the image requires capturing of an image of a color reference card.

4. The method according to claim 1 , wherein the correlation for transforming color formation of the test field into the analyte concentration comprises transforming an item of color information derived from the image into the analyte concentration.

5. A method of controlling analytical measurements using a mobile device having a camera, the method comprising:

I) a data collection process comprising:

(a) carrying out a plurality of analytical measurements, wherein the analytical measurements at least partly comprise capturing images of at least a part of an optical test strip having a test field by using the camera and further comprise capturing images of a color reference card;

(b) evaluating the plurality of analytical measurements and thereby determining a correlation configured for transforming color formation of the test field into an analyte concentration value without requiring using the color reference card;

© determining a level of confidence for the correlation determined in step (b);

(d) setting an item of clearance information indicating the level of confidence for the correlation; and

II) determining the concentration of an analyte in a body fluid with a process comprising:

using the camera to capture an image of at least a part of an optical test strip having a test field;

determining the analyte concentration value from color formation of the test field;

providing, in the mobile device, the correlation for transforming color formation of the test field into the analyte concentration value;

providing, in the mobile device, the item of clearance information indicating a level of confidence for the correlation; and

when the item of clearance information indicates a sufficient level of confidence for the correlation, the mobile device providing an indication to a user that the capturing of the image does not require using a color reference card.

6. The method according to claim 5 , wherein step (b) comprises evaluating the images captured in step (a) and thereby identifying similarities in at least some of the images.

7. The method according to claim 6 , wherein the identifying of similarities in at least some of the images comprises identifying similarities in groups of the images.

8. The method according to claim 5 , wherein step (b) comprises using an artificial neural network.

9. The method according to claim 5 , wherein step (d) comprises comparing the level of confidence with a predetermined threshold value, and, based on the comparison, setting the item of clearance information to a value indicating an insufficient level of confidence for measurements without using the color reference card or a sufficient level of confidence for measurements without using the color reference card, respectively.

10. A system for controlling analytical measurements, the system comprising: a mobile device having a camera; and wherein the system is configured for carrying out the method according to claim 5 .

11. The system according to claim 10 , further comprising an evaluation device configured for performing at least steps (b), (c) and (d).

12. The system according to claim 11 , wherein the evaluation device is separate from the mobile device and is configured for communicating with the mobile device, wherein the evaluation device is configured for transmitting the item of clearance information to the mobile device.

13. A non-transitory computer readable medium having stored thereon computer-executable instructions for the mobile device having the camera to perform the method of claim 1 .

14. A mobile device having a camera, the mobile device being configured for performing the method of determining a concentration of an analyte in a body fluid according to claim 1 .

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2022
From: ROCHE DIABETES CARE GMBH
To: ROCHE DIABETES CARE, INC.
Reel/Frame 060871/0483 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2022
From: CHITTAJALLU, SIVA; AYSIN, BENHUR
To: ROCHE DIABETES CARE, INC.
Reel/Frame 060871/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2022
From: BERG, MAX
To: ROCHE DIABETES CARE GMBH
Reel/Frame 061713/0458 →
Priority Claims (1)
EP 20153174 · Jan 22, 2020 · regional
Continuity (3)
Continuation PCTEP2020083086 · Nov 23, 2020
Provisional Application 62939771 · Nov 25, 2019
Related Publication 20220283148A1 · Sep 8, 2022
References Cited (34)
US 6122042A · Wunderman et al. · 2000 [cited by applicant]
US 7313141B2 · Kan · 2007 [cited by examiner]
US 8236516B2 · Evelegh · 2012 [cited by examiner]
US 9857373B1 · Pulitzer · 2018 [cited by examiner]
US 10267813B1 · Bhatia · 2019 [cited by examiner]
US 10277877B2 · Peterson et al. · 2019 [cited by applicant]
US 10527635B1 · Bhatia · 2020 [cited by examiner]
US 10545163B1 · Kowalchuk · 2020 [cited by examiner]
US 10816538B2 · Kluckner · 2020 [cited by examiner]
US 11022620B2 · Kluckner · 2021 [cited by examiner]
US 11386291B2 · Kluckner · 2022 [cited by examiner]
US 20050003468A1 · Evelegh · 2005 [cited by examiner]
US 20100167264A1 · Lee · 2010 [cited by examiner]
US 20110223673A1 · Profitt · 2011 [cited by examiner]
US 20120028245A1 · Lee · 2012 [cited by examiner]
US 20130137121A1 · Wang · 2013 [cited by examiner]
US 20130267032A1 · Tsai · 2013 [cited by examiner]
US 20160080548A1 · Erickson et al. · 2016 [cited by applicant]
US 20220270720A1 · Aysin · 2022 [cited by examiner]
EP 0612035A1 · 1994 [cited by applicant]
EP 1051687B1 · 2003 [cited by applicant]
EP 2916117A1 · 2015 [cited by applicant]
EP 3477270A1 · 2019 [cited by applicant]
EP 3825691A1 · 2021 [cited by applicant]
TW 202132762A · 2021 [cited by applicant]
WO WO9953288A2 · 1999 [cited by applicant]
WO WO2012131386A1 · 2012 [cited by applicant]
WO WO2015007153A2 · 2015 [cited by applicant]
WO WO2017065735A1 · 2017 [cited by applicant]
WO WO2018141429A1 · 2018 [cited by applicant]
WO WO2018224442A1 · 2018 [cited by applicant]
WO WO2019081460A1 · 2019 [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority, PCT/EP2020/083086, Mar. 26, 2021, 8 pages. [cited by applicant]
Hones et al., The Technology Behind Glucose Meters: Test Strips, Diabetes Technology & Therapeutics, vol. 10, Supplement 1, 2008, pp. S-10-S-26. [cited by applicant]